Other Species / Isoforms
  RBM30 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K27-ub
SLFEQYGkVLECDII
0 16
RBM30 (human) SLFEQYGkVLECDII K27-ub
RBM30 (mouse) SLFEQYGKVLECDII K27
RBM30 (rat) SLFEQYGKVLECDII K27
K45-ub
GFVHIEDkTAAEDAI
0 4
RBM30 (human) GFVHIEDkTAAEDAI K45-ub
RBM30 (mouse) GFVHIEDKTAAEDAI K45
RBM30 (rat) GFVHIEDKTAAEDAI K45
S70-p
VNINVEAsKNKSKAS
0 1
RBM30 (human) VNINVEAsKNKSKAS S70-p
RBM30 (mouse) VNINVEASKNKSKAS S70
RBM30 (rat) VNINVEASKNKSKAS S70
S86-p
KLHVGNIsPtCTNQE
Upstream
0 25
Treatment
  • nocodazole
RBM30 (human) KLHVGNIsPtCTNQE S86-p
RBM30 (mouse) KLHVGNIsPTCTNQE S86-p
RBM30 (rat) KLHVGNIsPTCTNQE S86-p
T88-p
HVGNIsPtCTNQELR
0 1
RBM30 (human) HVGNIsPtCTNQELR T88-p
RBM30 (mouse) HVGNIsPTCTNQELR T88
RBM30 (rat) HVGNIsPTCTNQELR T88
Y101-p
LRAKFEEyGPVIECD
0 28
RBM30 (human) LRAKFEEyGPVIECD Y101-p
RBM30 (mouse) LRAKFEEYGPVIECD Y101
RBM30 (rat) LRAKFEEYGPVIECD Y101
Y113-p
ECDIVKDyAFVHMER
0 30
RBM30 (human) ECDIVKDyAFVHMER Y113-p
RBM30 (mouse) ECDIVKDYAFVHMER Y113
RBM30 (rat) ECDIVKDYAFVHMER Y113
K139-ac
DNTEFQGkRMHVQLS
0 12
RBM30 (human) DNTEFQGkRMHVQLS K139-ac
RBM30 (mouse) DNTEFQGKRMHVQLS K139
RBM30 (rat) DNTEFQGKRMHVQLS K139
K139-ub
DNTEFQGkRMHVQLS
0 9
RBM30 (human) DNTEFQGkRMHVQLS K139-ub
RBM30 (mouse) DNTEFQGKRMHVQLS K139
RBM30 (rat) DNTEFQGKRMHVQLS K139
S160-p
APGMGDQsGCYRCGK
0 2
RBM30 (human) APGMGDQsGCYRCGK S160-p
RBM30 (mouse) APGMGDQSGCYRCGK S160
RBM30 (rat) APGMGDQSGCYRCGK S160
K173-ub
GKEGHWSkECPVDRT
0 1
RBM30 (human) GKEGHWSkECPVDRT K173-ub
RBM30 (mouse) GKEGHWSKECPVDRT K173
RBM30 (rat) GKEGHWSKECPVDRT K173
Y190-p
VADFTEQyNEQyGAV
0 2
RBM30 (human) VADFTEQyNEQyGAV Y190-p
RBM30 (mouse) VADFTEQYNEQYGAV Y190
RBM30 (rat) VADFTEQYNEQYGAV Y190
Y194-p
TEQyNEQyGAVRTPY
Upstream
0 13
Treatment
  • Su11274
RBM30 (human) TEQyNEQyGAVRTPY Y194-p
RBM30 (mouse) TEQYNEQYGAVRTPY Y194
RBM30 (rat) TEQYNEQYGAVRTPY Y194
Y205-p
RTPYTMGyGEsMyYN
0 1
RBM30 (human) RTPYTMGyGEsMyYN Y205-p
RBM30 (mouse) RTPYTMGYGESMYYN Y205
RBM30 (rat) RTPYTMGYGESMYYN Y205
S208-p
YTMGyGEsMyYNDAy
0 1
RBM30 (human) YTMGyGEsMyYNDAy S208-p
RBM30 (mouse) YTMGYGESMYYNDAY S208
RBM30 (rat) YTMGYGESMYYNDAY S208
Y210-p
MGyGEsMyYNDAyGA
0 2
RBM30 (human) MGyGEsMyYNDAyGA Y210-p
RBM30 (mouse) MGYGESMYYNDAYGA Y210
RBM30 (rat) MGYGESMYYNDAYGA Y210
Y215-p
sMyYNDAyGALDYYK
0 1
RBM30 (human) sMyYNDAyGALDYYK Y215-p
RBM30 (mouse) SMYYNDAYGALDYYK Y215
RBM30 (rat) SMYYNDAYGALDYYK Y215
S304-p
SYYGRDRsPLRRAAA
0 13
RBM30 (human) SYYGRDRsPLRRAAA S304-p
RBM30 (mouse) SYYGRDRsPLRRNAA S302-p
RBM30 (rat) SYYGRDRsPLRRNAA S302-p
Y340-p
AATRNSLyDMARYER
Upstream
0 225
Treatment
  • U0126
RBM30 (human) AATRNSLyDMARYER Y340-p
RBM30 (mouse) AATRNSLYDMARYER Y338
RBM30 (rat) AATRNSLYDMARYER Y338
Y350-p
ARYEREQyVDRARYS
0 3
RBM30 (human) ARYEREQyVDRARYS Y350-p
RBM30 (mouse) ARYEREQYVDRTRYS Y348
RBM30 (rat) ARYEREQYVDRARYS Y348